AB Science has been invited at four international meetings to present new preclinical data showing

development and marketing of protein kinase inhibitors (PKIs), announces it has been invited to present at four international meetings during 2016 abstracts reporting on new preclinical studies of masitinib in the treatment of amyotrophic lateral sclerosis ...